[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AnotherBio Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1364531118830219266.png) AnotherBioInvestor [@AnotherBio](/creator/twitter/AnotherBio) on x 1118 followers
Created: 2025-07-09 18:43:28 UTC

Ladies and gents, since it is officially shitco season, time to check what we can still gobble up from the dumpsters. May I present: $FGEN

In short:
- Trades at XX% of net cash after asset sale to AstraZeneca closes
- runway into H2 XX
- Phase X mCRPC data of its ADC + PET Imaging Agent coming up in H2 XX
- "maybe there´s a chance" revival of Roxadustat in US in H2 2025, hopefully with a partner
- Lo and behold - Insider Buys!

Stock has a horrible history, with lead asset Roxadustat failing in US (approved and reasonably successful marketed in China with Astrazeneca).

Why is the stock cheap and / or misunderstood? A 🧵


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1943018179225137356/c:line.svg)

**Related Topics**
[revival](/topic/revival)
[alternative investment](/topic/alternative-investment)
[$fgen](/topic/$fgen)
[$azn](/topic/$azn)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/AnotherBio/status/1943018179225137356)